fbpx Skip to main content

Comment Letters

Biocom is actively engaged in submitting comments to federal health agencies on draft guidances and proposals. We monitor and engage in important regulatory and reimbursement matters on behalf of the California life science community. Members are notified of draft guidances and proposals that are open for consideration by email and in our Regulatory Affairs Communique (RAC) Newsletter.

We also encourage members to contact us if there is an issue they would like us to engage in. Our positions are thoroughly vetted by our Regulatory Affairs, Federal, and Board-level policy committees before submission.

Biocom Comment Letters

Additional Resources